Advisors Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$215K Sell
12,544
-3,753
-23% -$64.2K ﹤0.01% 1110
2025
Q1
$1.04M Buy
16,297
+4,728
+41% +$302K 0.02% 737
2024
Q4
$1.41M Sell
11,569
-3,300
-22% -$401K 0.03% 649
2024
Q3
$1.86M Buy
14,869
+43
+0.3% +$5.37K 0.03% 581
2024
Q2
$2.34M Buy
14,826
+675
+5% +$107K 0.05% 494
2024
Q1
$1.83M Buy
14,151
+736
+5% +$95.3K 0.04% 576
2023
Q4
$1.29M Sell
13,415
-9,289
-41% -$896K 0.03% 655
2023
Q3
$2.75M Buy
22,704
+1,335
+6% +$162K 0.06% 397
2023
Q2
$2.45M Buy
21,369
+3,910
+22% +$448K 0.05% 449
2023
Q1
$2.41M Buy
17,459
+675
+4% +$93K 0.05% 463
2022
Q4
$2.17M Buy
16,784
+65
+0.4% +$8.42K 0.04% 476
2022
Q3
$1.85M Buy
16,719
+5,998
+56% +$663K 0.04% 524
2022
Q2
$804K Sell
10,721
-10,764
-50% -$807K 0.02% 815
2022
Q1
$1.68M Sell
21,485
-2,295
-10% -$179K 0.03% 637
2021
Q4
$2.14M Buy
23,780
+229
+1% +$20.6K 0.03% 583
2021
Q3
$2.18M Sell
23,551
-191
-0.8% -$17.7K 0.03% 566
2021
Q2
$1.85M Buy
23,742
+3,296
+16% +$256K 0.03% 620
2021
Q1
$1.52M Buy
20,446
+6,771
+50% +$505K 0.02% 684
2020
Q4
$2.33M Buy
13,675
+5,133
+60% +$875K 0.04% 489
2020
Q3
$1.2M Buy
8,542
+3,672
+75% +$516K 0.02% 653
2020
Q2
$781K Buy
4,870
+3,481
+251% +$558K 0.02% 758
2020
Q1
$136K Sell
1,389
-526
-27% -$51.5K ﹤0.01% 1177
2019
Q4
$247K Sell
1,915
-1,960
-51% -$253K ﹤0.01% 1151
2019
Q3
$292K Buy
3,875
+50
+1% +$3.77K 0.01% 1100
2019
Q2
$581K Buy
3,825
+14
+0.4% +$2.13K 0.01% 961
2019
Q1
$454K Buy
3,811
+338
+10% +$40.3K 0.01% 1101
2018
Q4
$379K Buy
3,473
+470
+16% +$51.3K 0.01% 1047
2018
Q3
$485K Buy
+3,003
New +$485K 0.01% 1066